Your funds, side by side
These are the lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Tema Oncology ETF Tema ETF Trust · 56 lines · as of May 31, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Tema Oncology ETF |
|---|---|
| REVOLUTION MEDICINES INC | 7.73 % |
| Eli Lilly & Co | 4.82 % |
| Roche Holding AG | 4.21 % |
| COGENT BIOSCIENCES INC | 4.10 % |
| Novartis AG | 4.03 % |
| Immunome Inc | 3.91 % |
| Celcuity Inc | 3.58 % |
| Merck & Co Inc | 3.57 % |
| AstraZeneca PLC | 3.54 % |
| Nuvalent Inc | 3.37 % |
| Bristol-Myers Squibb Co | 3.30 % |
| LEGEND BIOTECH CORP | 2.99 % |
| AbbVie Inc | 2.81 % |
| Exelixis Inc | 2.78 % |
| Bridgebio Pharma Inc | 2.75 % |
| Johnson & Johnson | 2.55 % |
| CG ONCOLOGY INC | 2.43 % |
| Genmab A/S | 2.37 % |
| Ideaya Biosciences Inc | 2.27 % |
| Amgen Inc | 2.11 % |
| ZAI LAB LTD | 1.98 % |
| BEONE MEDICINES LTD | 1.88 % |
| Zymeworks Inc | 1.51 % |
| Enliven Therapeutics Inc | 1.31 % |
| Relay Therapeutics Inc | 1.28 % |
| Halozyme Therapeutics Inc | 1.23 % |
| Summit Therapeutics Inc | 1.21 % |
| ARCUS BIOSCIENCES INC | 1.20 % |
| Gilead Sciences Inc | 1.12 % |
| IMMATICS NV | 1.12 % |
Titelia read 56 lines in these 1 funds.